Join Early Access Now

Lumina

Treatment is over.
Recovery has barely begun.

Post-cancer fatigue, immune dysregulation and persistent inflammation have a biological cause in most survivors and that cause is usually measurable. Lumina Health tracks it with the lab monitoring oncology follow-up doesn't currently include.

Join Early Access Now

Treatment ends  ·  Monitoring begins

The Evidence

0%

of cancer survivors report significant fatigue after treatment ends

— Bower et al., J Clin Oncol, 2014

0%

of post-chemotherapy patients have at least one major micronutrient deficiency

— Laviano et al., Nutr Clin Pract, 2012

3–5YEARS

average duration of post-cancer fatigue without targeted nutritional intervention

— Bower & Lamkin, Brain Behav Immun, 2013

Lumina

This fatigue is measurable. And it's treatable. Here's how.

Join Early Access Now

Our Solution

Lab monitoring built around one under-served moment in cancer recovery.

Lumina Health exists because a specific gap opens the moment active treatment ends: oncology follow-up watches for recurrence, not for the depletion that drives post-cancer fatigue, immune dysregulation and persistent inflammation. That depletion is common, measurable and correctable, yet no one checks the numbers once survivors leave active care. Lumina closes that gap with structured, repeated testing built around your specific treatment history rather than a single snapshot. Every panel is reviewed by a registered oncology dietitian and read against your own baseline over six months. That lets you see whether recovery is actually trending, or failing to, while there's still time to adjust with your care team.

A single reading is a snapshot. Tracked against your own baseline over time, it becomes objective evidence of recovery.

What the programme includes

The panel covers three areas: energy co-factors, immune micronutrients and inflammatory biomarkers, each chosen based on oncology dietetics research.
The same marker can mean very different things depending on how you were treated, so your results are read against the specific chemotherapy agents, radiation sites and hormone therapy in your history.
Every supplement we recommend is checked against known interactions with hormone therapies, aromatase inhibitors and other common adjuvant treatments.
Because you're tested over time, not just once, you and your care team can see whether fatigue and inflammation are actually moving in the right direction rather than assuming they are.

How it works

Recovery timeline

Month 1

Start with a baseline panel and a review of your treatment history: the 16-marker blood draw, plus an intake form covering your cancer type, treatment agents, current symptoms and medications.

Month 1–2

Your supplementation plan: specific doses, which product grades to use and a 12-week schedule, all reviewed by a registered oncology dietitian.

Month 3

First retest and adjustment: confirm the acute deficiencies have corrected, then adjust doses for the second phase based on where your labs are trending and how your symptoms have responded.

Month 6

Final panel and maintenance plan: a full comparison across all your retests, plus a written plan for keeping things steady on your own, with guidance on annual review.

Lumina

Limited availability.

Due to limited availability, we strongly encourage you to join early access now and start benefiting from this product.

Join Early Access Now

FAQs

Before you begin.

Yes. Your health information is kept confidential, stored securely and only your assigned clinical team sees your results.
Yes, with the right checks in place. Some micronutrients interact with specific treatments, high-dose antioxidants and certain targeted therapies being one example. Before any plan is issued, your report is checked against your treatment list. Where an interaction is possible, we flag it and ask you to raise it with your oncologist before starting. We never work against your oncology team's guidance.
Lumina accepts survivors from 8 weeks after final treatment onwards, with no upper limit. Many clients join two to five years out, having lived with fatigue or repeated infections that never resolved and never got explained. If you're still in active treatment, we can add you to the pre-registration waitlist for when you become eligible.
We work with survivors of solid tumours, including breast, colorectal, lung, prostate, gynaecological, head and neck and thyroid and of haematological cancers, including lymphoma, leukaemia and myeloma. The panel and its interpretation are tailored to your treatment: platinum-based chemotherapy leaves a very different deficiency profile from hormone therapy and the reporting reflects that.
NHS reference ranges are built for the general population, and their job is to catch frank disease, not to define what recovery after cancer treatment should look like. On the NHS, vitamin D counts as adequate at 50 nmol/L and above; Lumina aims for 75 to 100. Serum magnesium can read normal while intracellular stores, where magnesium does most of its work, stay low. The Lumina panel reads against thresholds set for where survivors should be, not just where the general population sits..

Join Early Acess Now

You survived treatment.
Now reclaim your health.

Register below and we'll send you our free clinical guide, The 7 Micronutrient Deficiencies That Prolong Post-Cancer Fatigue, straight to your inbox. Your waitlist place is confirmed the moment you submit.

Join Early Access

Name and Surname(Required)
Country(Required)
City(Required)
Products(Required)
How did you hear about us?(Required)

Your information is confidential, protected, and will only be used to personalise your recovery guide. You may unsubscribe at any time.

GDPR compliant Oncology dietitian reviewed UKAS-accredited labs Peer-cited protocol
Join Early Access Now

Thank you

We will contact you as soon as possible